The present study suggests that downregulation of AMFR expression in the latent and chronic stages impairs oligomerization of EAAT2, which suggests that the induction of AMFR expression should be considered an important strategy for treating epilepsy in both stages. Here, SLC1A2 is linked to epilepsy.